Ligand Pharmaceuticals, Inc. (LGND)
322.75
+5.42
(+1.71%)
USD |
NASDAQ |
Oct 30, 16:00
322.48
-0.27
(-0.08%)
After-Hours: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 6.429B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 72.54% |
| Valuation | |
| PE Ratio | 143.97 |
| PE Ratio (Forward) | |
| PS Ratio | 26.33 |
| Price to Book Value | 6.645 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 1.173 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 72.85% |
Profile
| Ligand Pharmaceuticals, Inc. is a biopharmaceutical company that involves clinical development and commercialization of high-value medicines. Its platforms, Captisol and NITRICI, offer technology with broad applicability in drug development to a large network of biopharmaceutical partners, including the largest pharmaceutical manufacturers in the world. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL. |
| URL | http://www.ligand.com |
| Investor Relations URL | https://investor.ligand.com/ |
| HQ State/Province | Florida |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Growth |
| Next Earnings Release | Feb. 25, 2027 (est.) |
| Last Earnings Release | Oct. 29, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Apr. 03, 2007 |
Profile
| Ligand Pharmaceuticals, Inc. is a biopharmaceutical company that involves clinical development and commercialization of high-value medicines. Its platforms, Captisol and NITRICI, offer technology with broad applicability in drug development to a large network of biopharmaceutical partners, including the largest pharmaceutical manufacturers in the world. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL. |
| URL | http://www.ligand.com |
| Investor Relations URL | https://investor.ligand.com/ |
| HQ State/Province | Florida |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Growth |
| Next Earnings Release | Feb. 25, 2027 (est.) |
| Last Earnings Release | Oct. 29, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Apr. 03, 2007 |